Cite
Salazar M, Lorente M, García-Taboada E, et al. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling. Mol Cell Oncol. 2015;2(3):e980134doi: 10.4161/23723556.2014.980134.
Salazar, M., Lorente, M., García-Taboada, E., Gómez, E. P., Dávila, D., Zúñiga-García, P., Flores, J. M., Rodríguez, A., Hegedus, Z., Mosén-Ansorena, D., Aransay, A. M., Hernández-Tiedra, S., López-Valero, I., Quintanilla, M., Sánchez, C., Iovanna, J. L., Dusetti, N., Guzmán, M., Francis, S. E., Carracedo, A., Kiss-Toth, E., & Velasco, G. (2015). TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling. Molecular & cellular oncology, 2(3), e980134. https://doi.org/10.4161/23723556.2014.980134
Salazar, María, et al. "TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling." Molecular & cellular oncology vol. 2,3 (2015): e980134. doi: https://doi.org/10.4161/23723556.2014.980134
Salazar M, Lorente M, García-Taboada E, Gómez EP, Dávila D, Zúñiga-García P, Flores JM, Rodríguez A, Hegedus Z, Mosén-Ansorena D, Aransay AM, Hernández-Tiedra S, López-Valero I, Quintanilla M, Sánchez C, Iovanna JL, Dusetti N, Guzmán M, Francis SE, Carracedo A, Kiss-Toth E, Velasco G. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling. Mol Cell Oncol. 2015 Apr 18;2(3):e980134. doi: 10.4161/23723556.2014.980134. eCollection 2015. PMID: 27308456; PMCID: PMC4905291.
Copy
Download .nbib